你即將離開本站

並前往https://www.jto.org/article/S1556-0864(16)30246-5/fulltext

136O: Osimertinib combined with durvalumab in EGFR-mutant ...

136O: Osimertinib combined with durvalumab in EGFR-mutant non-small cell lung cancer: Results from the TATTON phase Ib trial. M.-J. Ahn.

確定！ 回上一頁

查詢 「Combined with」的人也找了：

  1. combined with用法
    2.
  2. Combined with A and B
    3.
  3. Combined into
    4.
  4. combined醫學中文
    5.
  5. Combined with
    6.
  6. Combine into
    7.
  7. combine醫學
    8.
  8. combine into用法
    9.